Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03816293 · ClinicalTrials.gov registry record · NA
SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections
A NA study, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 3,680
- Enrollment target
NCT03816293 is a NA study that has completed, run by University of Illinois at Chicago. The registered enrollment target is 3,680 participants.
The verdict
NCT03816293, a NA study, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,680 participants
- Enrollment target
Study Summary
Our goal is to provide data that will give surgeons and hospitals clear recommendations on the use of NPWT for Cesarean section, abdominal hysterectomy and colon surgeries in patients with diabetes and/or obesity. We also want to understand the patient experience with the dressing so that we can provide information that will enable clinicians to remove barriers to NPWT use. Additionally, we are seeking to use automated electronic medical record decision support to identify patients that will benefit most from the NPWT.
Interventions
- DEVICE Negative Pressure Wound Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,680 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03816293
The ClinicalTrials.gov registry entry for NCT03816293 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,680 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Negative Pressure Wound Therapy is the first listed.
NCT03816293 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03816293 about?
NCT03816293 is a clinical study titled "SUpPress SSI - Single Use Negative Pressure Wound Therapy (NPWT) to Reduce Surgical Site Infections". Our goal is to provide data that will give surgeons and hospitals clear recommendations on the use of NPWT for Cesarean section, abdominal hysterectomy and colon surgeries in patients with diabetes and/or obesity. We also want to understand the patient experience with the dressing so that we can pro...
What is the current status of trial NCT03816293?
This trial is currently completed. It is a NA study. The enrollment target is 3,680 participants. The study started on 2019-05-01. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT03816293?
The interventions under investigation include: Negative Pressure Wound Therapy (DEVICE).
Who is sponsoring clinical trial NCT03816293?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.